Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02658240 · ClinicalTrials.gov registry record · NA
Ultrasound-guided Fascia Iliaca Compartment Block Versus Periarticular Infiltration
A NA study of Postoperative Pain, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT02658240: Completed NA study of Postoperative Pain, sponsored by University of Texas Southwestern Medical Center.
NCT02658240 is a NA study of Postoperative Pain that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 60 participants, below the 231-participant average among 120 other Postoperative Pain trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02658240, a NA study of Postoperative Pain, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
This randomized, controlled, observer-blinded study clinical trial was designed to evaluate ultrasound-guided fascia iliaca compartment block with ropivacaine and periarticular infiltration with ropivacaine for postoperative pain management after total hip arthroplasty.
Primary Outcome
The Visual Analog Pain Score (VAS) at resting on the scale of 10 (0= No pain, 10= Worst pain) at 48 hours postoperatively
Conditions Studied
Interventions
- DRUG Epinephrine
- DRUG Ropivacaine
Study Locations (1)
Texas
- UTSW Parkland Health Hospital System - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2016-04-05 |
| Est. Completion | 2017-12-16 |
| Phase | NA |
What the finished NCT02658240 record still lists
NCT02658240 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 231-participant average among 120 other Postoperative Pain trials with a reported enrollment target (74% lower).
The record links to 1 condition, with Postoperative Pain appearing as the primary indexed condition, and to 2 interventions - of which Epinephrine is the first listed.
NCT02658240 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT02658240 about?
NCT02658240 is a clinical study titled "Ultrasound-guided Fascia Iliaca Compartment Block Versus Periarticular Infiltration". This randomized, controlled, observer-blinded study clinical trial was designed to evaluate ultrasound-guided fascia iliaca compartment block with ropivacaine and periarticular infiltration with ropivacaine for postoperative pain management after total hip arthroplasty.
What is the current status of trial NCT02658240?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2016-04-05. Estimated completion is 2017-12-16.
What conditions does trial NCT02658240 study?
This clinical trial studies the following conditions: Postoperative Pain.
What interventions are being tested in trial NCT02658240?
The interventions under investigation include: Epinephrine (DRUG), Ropivacaine (DRUG).
Who is sponsoring clinical trial NCT02658240?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02658240 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postoperative Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02658240's enrollment target sits among peer trials
60 97th of 120 higher than 22 of 120 other Postoperative Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Postoperative Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Opioid Prescribing Practices in Laparoscopic Gynecologic Surgery
RECRUITING · NA
-
Virtual Reality and Olfactory Stimuli Multimodal Intervention to Reduce Post-Operative Pain and Anxiety in Patients Undergoing Cardiothoracic Surgery
RECRUITING · NA
-
Rectus Sheath Block in Cardiac Surgery
RECRUITING · NA
-
Pain With Differing Insufflation Pressures During Laparoscopic Hysterectomy
RECRUITING · NA
-
Effects of Assisted Robotic vs Laparoscopic Sleeve Gastrectomy
RECRUITING · NA
-
Postoperative Pain Control in AIS Using Liposomal Bupivacaine vs. 0.25% Bupivacaine With Epinephrine
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI